CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Medtronic MiniMed, Inc. recalls InPen App

Read the official FDA notice

Published
24 Dec 2025
Units affected
8251
Agency
FDA
Country
United States

The hazard

When app is uninstalled and reinstalled, insulin pen software issue causes Choose Notification Style Screen to not show during setup so users can't choose to allow notifications to override phone settings when on mute/Do Not Disturb, and previously set up override permission is deleted, so audible and vibratory notifications not received, which may lead to delayed insulin therapy, hyperglycemia.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

InPen App, Model/CFN Number: MMT-8061 (Android Users)

Brand / company
Medtronic MiniMed, Inc.
Codes / lots
Software Versions: 7.5.0, 7.5.1, and 8.0.0. UDI-DI: 00763000974596
Distribution
US: IL, AZ, MN, NE, KS, TN, CA, FL, TX, WA, MO, NC, NY, WI, IN, ME, CT, RI, MD, PA, OK, KY, MA, DE, UT, ID, VA, MI, OH, LA, NJ, IA, MT, HI, AR, OR, SC, AL, CO, WY, VT, NV, GA, MS, SD, AK, WV, NH, ND, NM. OUS: Austria, Belgium, Chile, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, South Africa, Spain, Sweden, Switzerland, United Kingdom
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 24 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.